Chime Financial, a fintech company focused on no-fee banking, made a strong Nasdaq debut, raising $864 million and highlighting its growing traction among underserved consumers.
BioNTech to acquire German rival CureVac in $1.25B all-stock deal, bolstering its mRNA capabilities.
Supreme Court revives lawsuit against FBI over mistaken home raid, setting precedent for law enforcement accountability.
Chime Financial, a fintech company focused on no-fee banking, made a strong Nasdaq debut, raising $864 million and highlighting its growing traction among underserved consumers.
BioNTech to acquire German rival CureVac in $1.25B all-stock deal, bolstering its mRNA capabilities.
Supreme Court revives lawsuit against FBI over mistaken home raid, setting precedent for law enforcement accountability.